Your browser is out-of-date!

Update your browser to view this website correctly.

Disclaimer
To continue, please select your country of domicile and investor type. Depending on your domicile and the investor type that you select, you will have full or restricted access to the information due to legal reasons.

Retail clients: according to Art. 4 Abs. 2 FinSA

Professional/Institutional investors: according to Art. 4 paragraph 3-5 and Art. 5 paragraph 1 and 3-4 FinSA and Art. 10 paragraph 3 and 3ter CISA in conjunction with Art. 6a CISO

Important

Principles 

By using the website www.bellevue.ch, you confirm that you have read, understood and accepted the general information provided by the Bellevue Group AG as well as these legal provisions. These may be subject to change and the use of the site may be restricted or terminated at any time without prior notice.

No recommendation and/or offer for subscription (or for purchase) and/or redemption (or for sale)

The information, products, data, services, tools and documents contained or described on this site ("website content") are for information purposes only and constitute neither an advertisement or recommendation nor an offer or solicitation (to buy) or redemption (sell) investment instruments, to effect any transaction or to enter into any legal relations.

The financial products mentioned on this site are not suitable for all investors. The information contained on this site does not constitute a financial, legal, fiscal or any other recommendation. Investment or other decisions should not be made solely on the basis of this document. In particular, you should not enter into any investment before you have read the corresponding fund agreement or legal prospectus, the annual and semi-annual reports, the articles of association (as far as they are applicable), as well as all other documents, as required in accordance with local legislation or the regulations applied in the legal jurisdictions or countries in which the corresponding investment fund has been licensed or approved for public offer or sale to the public.rlich sind.

The financial products mentioned on this site are not suitable for all investors. The information contained on this site does not constitute a financial, legal, fiscal or any other recommendation. Investment or other decisions should not be made solely on the basis of this document. In particular, you should not enter into any investment before you have read the corresponding fund agreement or legal prospectus, the annual and semi-annual reports, the articles of association (as far as they are applicable), as well as all other documents, as required in accordance with local legislation or the regulations applied in the legal jurisdictions or countries in which the corresponding investment fund has been licensed or approved for public offer or sale to the public.

In order to determine whether the investment in shares of a certain investment fund meets your specific requirements and matches your envisaged risks, we recommend that you contact an independent financial adviser. Furthermore, we recommend that you consult an independent tax adviser in order to obtain information on the tax regulations relating to a specific investment in your legal jurisdiction and with regard to your personal circumstances. In particular tax treatment depends on individual circumstances and may be subject to change.

As the funds are recognised (ie. registered) but not authorised in the UK, the UK Financial Services Authority's financial services compensation scheme does not apply to investments in the fund but the Financial Services Authority regulated firm approving this document for the purposes of UK regulation has taken reasonable steps to satisfy itself that Bellevue will deal in an honest and reliable way and is so satisfied.

Performance

Past performance is not an indication or guarantee of the future performance of the investment. The value of investments may be subject to fluctuations and, under certain circumstances, investors may not get back the full amount invested. The performance data are calculated without taking account of commissions and costs that result from subscriptions and redemptions and commissions and costs have a negative impact on performance. Changes in foreign-exchange rates may also cause the value of investments to go up or down.

Target group of the sites 

The sites are intended exclusively for use by legal entities and natural persons having their registered office or residing in countries in which the investment funds or the related subfunds or share classes of the Bellevue Group have been properly licensed or approved for public offer or sale in accordance with the applicable local legislation. The funds are currently registered for public distribution offer in the following countries: Luxembourg, Switzerland, Germany, Austria, Spain and Portugal. In all other countries, the funds may, if any, via "Private Placement" according to the local applicable laws.

It is explicitly stated, that alternative fund products are not allowed for public distribution in any country and that they may only and exclusively be solicited to institutional and qualified private investors according to the applicable local laws of each country.

The information and services provided on the sites are not intended for offer to or use by legal entities or natural persons in legal jurisdictions or countries in which the offer or use thereof would violate local legislation or legal provisions, or in which business units forming part of Bellevue Group would be subject to registration requirements in such jurisdictions or countries. Legal entities or natural persons to which such prohibitions apply must not access or use these sites.

The Bellevue funds have NOT been licensed for public offer or sale to the public in the United States in accordance with the US Investment Company Act of 1940 or the US Securities Act of 1933, or in Canada, Japan, Taiwan, Malaysia, Hong Kong or Israel in accordance with the laws in force in those countries. Therefore, particular importance is attached to ensuring that these sites are not intended for legal entities or natural persons, who have their registered office or who reside in such countries, their territories or dependencies or who, on account of their citizenship or similar status, are subject to the law of one of these countries.

Fund documents Luxembourg Fund

Bellevue SICAV: The Bellevue Funds (Lux) SICAV is admitted for public offering and distribution in Switzerland . Representative agent in Switzerland   Waystone Fund Services (Switzerland) SA, Avenue Villamont 17, CH-1005 Lausanne and paying agent in Switzerland: DZ PRIVATBANK (Schweiz) AG Münsterhof 12, PO Box, CH-8022 Zürich. Austria: Paying and information agent: Zeidler Legal Process Outsourcing Limited., 19-22 Lower Baggot Street, Dublin 2, D02 X658, Ireland. Germany: information agent: Zeidler Legal Process Outsourcing Limited., 19-22 Lower Baggot Street, Dublin 2, D02 X658, Ireland. Spain: The Bellevue Funds (Lux) SICAV is registered with the CNMV under the number 938. Paying and information agent: atl Capital, Calle de Montalbán 9, ES-28014 Madrid.  Prospectus, Key Investor Information Document (“KID”), the articles of association as well as the annual and semi - annual reports of the Bellevue Funds under Luxembourg law are available free of charge from the above mentioned representative, paying, facilities and information agents as well as from Bellevue Asset Management AG, Seestrasse 16 , CH - 8700 Kusnacht. 

Bellevue Asset Management (Deutschland) GmbH: You can obtain the sales prospectus, the annual reports and the german key investor information documents free of charge from Bellevue Asset Management (Deutschland) GmbH, and also from banks and financial advisers. Paying agent in Switzerland is DZ PRIVATBANK (Schweiz) AG, Münsterhof 12, PO Box, CH-8022 Zurich. The swiss agent is IPConcept (Schweiz) AG, In Gassen 6, PO Box, CH-8022 Zurich. In Switzerland you can obtain sales prospectus, the annual reports and the german key investor information documents free of charge from the agent and also from the paying agent. 

Fund documents Bellevue Entrepreneur Switzerland

Prospectus, Key Investor Information Document („KID“), fund contract as well as the annual and semi - annual reports of the Bellevue Fund under Swiss law are available free of charge from: Switzerland : PMG Fonds Management AG, Dammstrasse 23, 6300 Zug or Bellevue Asset Management AG, Seestrasse 16, CH - 8700 Kusnacht. 

Fund documents Bellevue Funds and Bellevue Healthcare Strategy

Prospectus, Key Investor Information Document („KID“), fund contract as well as the annual and semi - annual reports of the Bellevue Medtech and Services fund established under Swiss law in the category "Other Funds for Traditional Investments" are available free of charge from : Switzerland : Swisscanto Fondsleitung AG, Bahnhofstrasse 9 , CH - 8001 Zürich or Bellevue Asset Management AG, Seestrasse 16 , CH - 8700 Kusnacht

Fund documents StarCapital Multi Income and StarCapital Dynamic Bonds

Prospectus, the key information document ("PRIIP-KID"), the management regulations and the semi-annual and annual report are available free of charge in German from Bellevue Asset Management (Deutschland) GmbH, your advisor or intermediary, the paying agents, the relevant custodian bank or from the management company IPConcept (Luxembourg) S.A. (société anonyme), 4, rue Thomas Edison, L-1445 Luxembourg, Luxembourg, https://www.ipconcept.com. For information on opportunities and risks as well as tax information, please refer to the current detailed sales prospectus. Further information on investor rights can be found on the Management Company's website (https://www.ipconcept.com). The management company may decide to cancel the arrangements it has made for the distribution of the units of its collective investment undertakings in accordance with Article 93a of Directive 2009/65/EC and Article 32a of Directive 2011/61/EU.

Fund documents Bellevue Option Premium fund

Prospectus, the key information document ("PRIIP-KID"), and the semi-annual and annual reports are available free of charge in German from Bellevue Asset Management (Deutschland) GmbH, your advisor or intermediary, the paying agents, the responsible depositary (UBS Europe SE, Bockenheimer Landstrasse 2-4, D-60306 Frankfurt am Main) or from the management company Universal-Investment-Gesellschaft mbH, Theodor-Heuss-Allee 70, D-60486 Frankfurt am Main, https://www.universal-investment.com. For information on opportunities and risks as well as tax information, please refer to the current detailed sales prospectus. Further information on investor rights can be found on the Management Company's website (https://www.universal-investment.com). The management company may decide to cancel the arrangements it has made for the distribution of the units of its collective investment undertakings in accordance with Article 93a of Directive 2009/65/EC and Article 32a of Directive 2011/61/EU.

Data protection

By accessing this website you state that you agree with the data protection statement. If you do not agree with this statement you should refrain from accessing any further pages of this website. This statement may be updated at any time. We therefore recommend that you check this statement regularly.

Confirmation

By clicking on "Accept", you confirm that you agree to the legal provisions. 

Legal & Services

Bellevue Asset Management is an authorized manager of collective assets of collective investment schemes subject to regulation by the Swiss Financial Market Supervisory Authority FINMA. As such, it is in compliance with all regulatory and legal requirements placed upon managers of collective investment schemes. Bellevue Asset Management is responsible for the operating activities of BB Biotech AG and for the investment management operations of the Bellevue Funds (Lux) SICAV and other investment funds and mandates.
 

Disclaimer / Tax consequences of investment transactions 

Investments can lose or gain in value. Past performance is not a guarantee of future performance. Potential investors should also obtain information about the potential tax consequences related to the purchase, ownership and sale of investment products at their place of domicile and seek advice from a tax specialist at their place of domicile. Please also take note of the brochure «Risks Involved in Trading Financial Instruments»​​​​​​​.

 

The Swiss Financial Services Act (FINSA)

INFORMATION FOR CLIENTS OF BELLEVUE ASSET MANAGEMENT AG

The Swiss Financial Services Act (FinSA) came into force on 1 January 2020. Its aims include strengthening investor protection and the Swiss financial centre, as well as creating comparable conditions for financial service providers. Most of the provisions will apply from January 2022 following a two-year transition period.

The FinSA essentially contains regulations on the provision of financial services and the offering of financial instruments and is intended to improve investor protection. In terms of content, the FIDLEG is closely aligned with the reforms of EU regulations and mainly covers the following areas:

 

 

  • Optimisation of investor protection
  • Transparency of financial products
  • Revision of organisational requirements for the provision of services

FinSA concerns all financial services provided to clients domiciled in Switzerland or to clients abroad from Switzerland.

Bellevue Asset Management AG is a wholly owned subsidiary of Bellevue Group AG. Bellevue Asset Management AG is subject to the Financial Institutions Act (FinIA) and is supervised by the Swiss Financial Market Supervisory Authority (FINMA) as a manager of collective assets of collective investment schemes.

CONTACT INFORMATION BELLEVUE ASSET MANAGEMENT AG 

Bellevue Asset Management AG
Seestrasse 16
CH-8700 Küsnacht
Tel. +41 44 267 67 00
Fax +41 44 267 67 01
info(at)bellevue.ch

CONTACT INFORMATION FINMA

Eidgenössische Finanzmarktaufsicht FINMA
Laupenstrasse 27
CH-3003 Bern
Tel. +41 31 327 91 00
Fax: +41 31 327 91 01
info(at)finma.ch

If you are not satisfied with our services, please get in touch with your contact person at Bellevue Asset Management AG. Alternatively, you can contact our Legal & Compliance department. The contact details are as follows:

Bellevue Asset Management AG
Legal & Compliance
Seestrasse 16
CH-8700 Küsnacht
Tel. +41 44 267 67 00
compliance(at)bellevue.ch

 

 

 

 

 

If we cannot find an amicable solution, you can contact the Swiss Financial Audit Office (FINOS), to which Bellevue Asset Management has affiliated itself. FINOS is a free and neutral information and mediation agency.

FINOS generally only becomes active after the client has confronted the manager of collective assets with the complaint in writing and the latter has had the opportunity to take a stand.

The contact details of FINOS are as follows:

Finanzombudsstelle Schweiz
Talstrasse 20
CH-8001 Zürich
Tel. Inland: 044 552 08 00
Tel. Ausland: +41 44 552 08 00
www.finos.ch
info(at)finos.ch

CLIENT CLASSIFICATION 

The legislation establishes three client classifications: ‘Retail’ (non professional), ‘Professional’ and ‘Institutional’ clients. A change of the client classification can be requested by the client in writing which results in changes in the product offering and investor protection at the same time.The following overview describes the three client classifications and their effects on investor protection.

 RetailProfessionalInstitutional
We carry out an appropriateness or suitability assessment when providing
investment advisory services , depending on the type of advice. In addition,
we carry out a suitability assessment when providing investment management
services. 
Yes 1)Yes 2)No
We document you needs and the reasons for our recommendation during the 
investment advisory process. 
YesYes 3)No
You have access to funds restricted to Qualified investors in accordance with 
the revised Collective Investment Schemes Act (CISA).
No 4)Yes 5)Yes
We provide you with a Key Information Document (KID) as part of our investment
advisory services when you purchase certain financial instruments. For «execution 
only» transactions, this information is only provided if available. 
YesNo 6)No 6)
We are obliged to obtain best execution when handling you securities order. YesYesNo

 

1 For “execution only” transactions without Credit Suisse advice, only Knowledge and Experience is checked for ‘Retail’ clients (non professional).

2 ‘For ‘Professional’ clients it can be assumed that they have the required level of knowledge and experience and that they can financially bear the investment risks associated with the financial service. For “execution only” transactions without Credit Suisse advice, neither an appropriateness nor a suitability assessment is conducted.

3 ‘Professional’ clients can waive advisory minutes so they are not being produced. Without the waiving request advisory minutes are provided to ‘Professional’ clients on request.

4 Exception: ‘Retail’ clients (non professional) having a long-term asset management or investment advisory mandate with a FINMA-licensed Swiss financial intermediary or a foreign financial intermediary subject to equivalent supervision (e.g. Credit Suisse) may be treated as ‘Qualified Investors’ pursuant to CISA and may receive advice related to funds restricted to ‘Qualified Investors’. Their classification according to FinSA remains ‘Retail’ (non professional) and is not impacted by their ‘Qualified Investors’ status.

 5 Being a ‘Professional’ client under FinSA, you become automatically a ‘Qualified Investors’ under CISA and have access to funds not meeting the Swiss distribution criteria (additional restrictions apply to funds without Swiss Representative and Paying Agent).

6 Except on client’s request.

Luxembourg Investment Funds

Bellevue Funds

CACEIS is responsible for fund administration, custodian services and order processing for our Luxembourg-based investment funds. We work with the following local partners in the markets where Bellevue funds are authorized for public distribution:  

Representative in Switzerland
Waystone Fund Services (Switzerland) SA
Avenue Villamont 17
CH-1005 Lausanne

Paying Agent in Switzerland
DZ Privatbank (Schweiz) AG
Münsterhof 12
Postfach 
CH-8022 Zürich

Main Sales Office
Bellevue Asset Management AG
Seestrasse 16
CH-8700 Küsnacht/Zürich 

Information Centre for Germany
Zeidler Legal Process Outsourcing Ltd.
19-22 Lower Baggot Street
Dublin 2, D02 X658
Ireland

Paying Agent and Information Centre in Austria
Zeidler Legal Process Outsourcing Ltd.
19-22 Lower Baggot Street
Dublin 2, D02 X658
Ireland

STARCAPITAL FUNDS 

DZ Privatbank S.A., is responsible for fund administration, custodian services and order processing for the StarCapital Luxembourg-based investment funds. We work with the following local partners: 

Representative and Paying Agent in Germany
DZ BANK AG
Deutsche Zentral-Genossenschaftsbank
Frankfurt am Main Platz der Republik
D-60265 Frankfurt am Main

Representative in Germany
StarCapital AG
Kronberger Straße 45
D-61440 Oberursel

Representative in Switzerland
IP Concept (Schweiz )AG
in Gassen 6, PO Box 
CH-8022 Zürich 

Paying Agent in Switzerland
DZ Privatbank (Schweiz) AG
Münsterhof 12, PO Box
CH-8022 Zürich 

Representative and Paying Agent in Austria
ERSTE BANK der oesterreichischen Sparkassen AG
Graben 21
A-1010 Wien

PURCHASE & REDEMPTION 

Our Luxembourg investment funds are traded on a daily basis. You can invest in Bellevue funds through your house bank or broker by giving the corresponding securities identification number (security number or ISIN) with your order.

Our funds are traded without any mark-up to Net Asset Value (NAV). Bellevue Asset Management does not charge a special commission on the purchase or redemption of fund units. A transaction fee might be charged by your house bank or broker.

We attach great importance to transparency and provide our clients with prompt, comprehensive information. Information on the prices of our funds can be found in the following newspapers published in Switzerland, Germany and Austria and on the following financial portals: Tageszeitungen in der Schweiz, Deutschland und Österreich sowie auf Finanzportalen: 

Here institutional investors and financial intermediaries will find detailed information on administrative procedures and contact details in connection with the purchase and sale of fund units

Swiss Investment Funds

Fund Management Bellevue Entrepreneur Switzerland
PMG Investment Solutions AG
Dammstrasse 23
6300 Zug

Custodian Bellevue Entrepreneur Switzerland
CACEIS Investor Services Bank S.A.
Esch-sur-Alzette
Zweigniederlassung Zürich

Fund Management Bellevue Funds
Swisscanto Fondsleitung AG
Bahnhofstrasse 9
8001 Zürich 

Custodian Bellevue Funds
Zürcher Kantonalbank
Geschäftshaus Hard A
Postfach
8010 Zürich 

We offer investment funds under Swiss law that are traded daily. You can invest in the funds at any time through your house bank or broker by giving the corresponding securities identification number (security number or ISIN) with your order.

The funds are traded without any mark-up to Net Asset Value (NAV). Bellevue Asset Management does not charge a special commission on the purchase or redemption of fund units. A transaction fee might be charged by your house bank or broker..

We attach great importance to transparency and provide our clients with prompt, comprehensive information. Information on fund prices can be found in the following daily and financial newspapers in Switzerland and on the following financial portals: 

  • NZZ
  • Finanz & Wirtschaft
  • www.fundinfo.com
  • www.zkb.ch Bloomberg
  • Reuters
  • Telekurs

Here institutional investors and financial intermediaries will find detailed information on administrative procedures and contact persons in connection with the purchase and sale of fund units: 

Investment Company

BB Biotech AG is a corporation listed on the SIX Swiss Exchange, in Germany (Prime Standard) and the "Segmento Star" in Italy and is domiciled in Schaffhausen, Schwertstrasse 6. Its business purpose is to invest in biotechnology companies. Asset management, administration and marketing responsibilities have been entrusted to Bellevue Group since the company was founded. 

The Board of Directors of BB Biotech AG consists of highly reputable and experienced industry professionals and scientists: 

  • Dr. Thomas von Planta, Chairman of the Board of Directors
  • Dr. Clive Meanwell, Member of the Board of Directors
  • Laura Hamill, Member of the Board of Directors
  • Dr. Pearl Huang, Member of the Board of Directors
  • Prof. Dr. Mads Krogsgaard Thomsen, Member of the Board of Directors
  • Camilla Soenderby, Member of the Board of Directors

For more information on BB Biotech please visit our website www.bbbiotech.com

 

Private Equity

The venture capital products were established under Guernsey law. 

Please contact us for information.

Bellevue Asset Management AG
Seestrasse 16 / Postfach
CH-8700 Küsnacht
Tel. +41 (0)44 267 67 00
Fax +41 (0)44 267 67 01
info(at)bellevue.ch  

Policies

All policies of Bellevue Asset Management AG are listed here